Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-04 @ 3:45 AM
Study NCT ID:
NCT02858492
Status:
COMPLETED
Last Update Posted:
2021-06-15
First Post:
2016-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-20
First Submit QC Date:
None
Study First Post Date:
2016-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-11
Results First Submit QC Date:
None
Results First Post Date:
2019-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-27
Last Update Post Date:
2021-06-15
Last Update Post Date Type:
ACTUAL